Chris Centeno

Director at Consano Bio.

Raised on Consano Bio filings

$51.7M

of $65.7M offered across 2 Form D filings

Form D filings: 2
Teammates: 9
Last filing: Mar 20, 2026

Company

Biotech · Burlington, MA

Biologic therapies for orthopedic injuries

Biologic therapies for orthopedic injuries

Investors: 18
Founded: 2022
Still open: $14M

Investors: 18
Sector: Biotech
Founded: 2022
HQ: Burlington, MA

Consano Bio filings

Consano Bio Form D filings
Filed	Security	Sold of offered	Filing
Mar 20, 2026	Equity	$34.8M/ $48.9M	Form D
Dec 12, 2025	Security to be acquired	$16.8M/ $16.8M	Form D

EquityFiled Mar 20, 2026Form D
$34.8M/ $48.9M
Security to be acquiredFiled Dec 12, 2025Form D
$16.8M/ $16.8M

Works with

Also named on Consano Bio filings

Andrew HallChief Executive Officer of Issuer, Form D signerForm D signer Jerome AdamsDirector John ConwayDirector Doug Vander WeideDirector Bill AbbingtonDirector Christopher CentenoDirector Jennifer SchmitkePresident and Chief Operating Officer of Issuer Joe SchieslDirector Michael PedeDirector